Drugs & Side Effects |

Cancer Drugs News

Monoclonal Antibody Drug Being Tested for Ovarian Cancer

RSS News Feeds
Drugs & Pharmacuticals
Cancer Drugs
Fosamax
 All RSS Feeds

At a glance:

The FDA has conferred "orphan drug" status for an ovarian cancer therapy under development. 
 
This has advantages for tax purposes and marketing exclusivity, meant to encourage companies to develop drugs for less common conditions. 
 
The drug, Morab-003, is a humanized monoclonal antibody.

Morphotek gets key FDA designation for drug

Philadelphia Business Journal - 6/21/2006 10:10 AM

The Food and Drug Administration has granted orphan drug status to an experimental drug being developed by Morphotek Inc. to treat ovarian cancer.
 
Known as Morab-003, the drug -- a humanized monoclonal antibody -- is in midstage clinical testing.
 
· Read The Full Cancer Drugs Article From Philadelphia Business Journal -->

· Read All Cancer Drugs News Stories -->

Comments On Cancer Drugs News Articles:

barbara
Comment On: Monoclonal Antibody Drug Being Tested for Ovarian Cancer
Posted by barbara on 5/10/2008 | Filed Under: Cancer Drugs

ZmDXLc g84nst394kldshg641h0


Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: